episode 1: oral serds in er breast cancer: efficacy, safety and treatment landscape
Published 2 days ago • 49 plays • Length 23:13Download video MP4
Download video MP3
Similar videos
-
25:28
episode 2: oral serds in er breast cancer: treatment selection and beyond
-
18:40
overview of clinical data of serds & their place in treatment landscape
-
26:18
episode 3: oral serds in er breast cancer: rare cases & treatment challenges
-
5:54
oral serds: new endocrine therapy options in er metastatic breast cancer - a patient case video
-
5:30
er metastatic breast cancer: elacestrant and beyond
-
0:30
the role of serds in the treatment landscape of patients with er /her2- breast cancer
-
9:44
navigating er metastatic breast cancer: explore a patient case
-
21:19
estrogen receptors & her2/neu receptors in breast cancer (a tutorial from oster oncology)
-
5:46
understanding serds for hr breast cancer treatment: what you need to know
-
1:31:23
breast cancer q&a webinar 11-20-2021
-
7:25
er breast cancer patient case video
-
8:08
karisa's story, chapter 1 - breast cancer treatment & survivorship
-
8:07
the history of breast cancer diagnosis, subtypes and treatment
-
11:22
treating er /her2-low metastatic breast cancer, 2l and beyond
-
7:18
optimising treatment selection for patients with er /her2- breast cancer
-
2:35
what does the future hold for serds in er breast cancer?
-
1:32:58
guideline video
-
20:37
gs2-02: "elacestrant, an oral selective estrogen receptor degrader (serd), vs investigator’s..."
-
2:01
meet breast surgical oncologist elizabeth fitzsullivan, m.d.